Robinson James A. Jr.
SEC CIK 1734295 · EDGAR
Most active insiders at URGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schoenberg Mark | Chief Medical Off | — | $4.48M |
| 2 | Smith Jason Drew | GC | — | $211.9K |
| 3 | Degnan Chris | CFO | — | $37.1K |
| 4 | Wildman Daniel George | Dir | — | — |
| 5 | WEN LEANA | Dir | — | — |
| 6 | Holden Stuart | Dir | — | — |
| 7 | Robinson James A. Jr. | Dir | — | — |
| 8 | BUTITTA CYNTHIA M | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-28 16:01 | 2026-08-26 | URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Dir | M - OptEx | — | +2,000 | 8,000 | +33% | — |
| D | 2026-05-27 08:04 | 2026-05-26 | URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Dir | M - OptEx | — | +2,000 | 6,000 | +50% | — |
| D | 2026-02-27 | 2025-02-26 | URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Dir | M - OptEx | — | +2,000 | 4,000 | +100% | — |
| D | 2026-01-16 | 2026-01-10 | ELDN | Eledon Pharmaceuticals, Inc. | Robinson James A. Jr. | Dir | M - OptEx | $0.00 | +3,430 | 3,430 | New | $0 |
| D | 2025-12-01 | 2025-11-26 | URGN | UroGen Pharma Ltd. | Robinson James A. Jr. | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
Purchase Sale Sale after option exercise All abbreviations